![Catarina Edfjäll](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Catarina Edfjäll
Geen lopende functies
Vermogen: - $ op 31-05-2024
Profiel
Catarina Edfjäll formerly worked at The Cancer Drug Development Forum, as Director from 2008 to 2012, International Collaboration On Rare Diseases & Orphan Drugs, as Director from 2014 to 2021, ObsEva SA, as Independent Director from 2021 to 2024, and CSL Behring AG, as Global Head-Regulatory Affairs from 2013 to 2019.
Dr. Edfjäll received her doctorate degree from the University of Basel and graduate degree from the University of Strasbourg.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
OBSEVA SA
-.--% | 24-03-2023 | 0 ( -.--% ) | - $ | 31-05-2024 |
Eerdere bekende functies van Catarina Edfjäll
Bedrijven | Functie | Einde |
---|---|---|
OBSEVA SA | Directeur/Bestuurslid | 18-03-2024 |
International Collaboration On Rare Diseases & Orphan Drugs | Directeur/Bestuurslid | 01-01-2021 |
CSL Behring AG
![]() CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The company is based in Bern, Switzerland. | Algemeen Adviseur | 01-01-2019 |
The Cancer Drug Development Forum | Directeur/Bestuurslid | 01-01-2012 |
Opleiding van Catarina Edfjäll
University of Basel | Doctorate Degree |
University of Strasbourg | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OBSEVA SA | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
The Cancer Drug Development Forum | |
International Collaboration On Rare Diseases & Orphan Drugs | |
CSL Behring AG
![]() CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The company is based in Bern, Switzerland. | Health Technology |